Real-World GUARDIANS Study Evaluates Enfortumab Vedotin–Pembrolizumab in Urothelial Cancer
Urothelial carcinoma, the most common form of bladder cancer, has entered a new therapeutic era with the arrival of a treatment strategy that attacks tumors...















